Related Experiment Videos
Clinical pharmacology of edrophonium in infants and children
Insights
Edrophonium doses for reversing neuromuscular blockade in infants and children are similar to adults, though with greater variability. Optimal atropine timing and edrophonium pharmacokinetics were also established in pediatric patients.
Area of Science:
- Anesthesiology
- Pharmacology
- Pediatric Medicine
Background:
- Understanding edrophonium's effects is crucial for safe pediatric anesthesia.
- Previous studies on edrophonium's dose-response, pharmacokinetics, and atropine interactions have primarily focused on adult populations.
- Limited data exists on these parameters in infants and children, necessitating specific investigation.
Purpose of the Study:
- To determine the dose-response relationship of edrophonium in antagonizing d-tubocurarine-induced neuromuscular blockade in infants and children.
- To investigate the onset, duration of action, and atropine requirements for edrophonium administration in pediatric patients.
- To characterize the pharmacokinetic variables of edrophonium in infants and children and compare them to adult values.
Main Methods:
- Steady-state infusion of d-tubocurarine was used to determine the ED50 for edrophonium in infants and children.
- Onset and duration of antagonism were assessed, along with optimal atropine timing and dosage.
- Pharmacokinetic parameters including distribution and elimination half-lives, distribution volumes, and total clearance were analyzed.
Main Results:
- The ED50 for edrophonium was determined to be 145 µg/kg in infants and 233 µg/kg in children, comparable to adult values (128 µg/kg), with greater variability in pediatric groups.
- Time to peak antagonism was similar across age groups; duration of antagonism did not differ significantly from adults.
- Optimal atropine administration (10 µg/kg) occurred 30 seconds prior to edrophonium (1 mg/kg) to minimize hemodynamic changes. Total clearance was highest in infants.
Conclusions:
- The dose of edrophonium required for antagonizing neuromuscular blockade is similar or potentially greater in infants and children compared to adults.
- Pediatric patients exhibit greater variability in response to edrophonium.
- Specific guidelines for atropine administration and understanding pharmacokinetic differences are important for pediatric use.
Abstract:
The dose-response relationship, onset, duration of action, atropine requirement, and pharmacokinetic variables of edrophonium were determined in infants and children during N2O-halothane anesthesia. The technique of steady state infusion of d-tubocurarine anesthesia. The technique of steady state infusion of d-tubocurarine (dTc) was used to determine the ED50 for edrophonium (i.e., the dose producing 50% antagonism of 90% neuromuscular depression) in 4 infants (145 micrograms/kg) and 12 children (233 microgram/kg). The reported values for ED50 for edrophonium (obtained under similar anesthetic conditions) is 128 micrograms/kg for adults. These three dose-response curves do not differ statistically; however, there was greater variability among infants and children than adults. Time to peak antagonism was similar for all three age groups. Duration of antagonism was determined in six infants and six children and did not differ from the reported value for adults. The optimal dose and time of administration of atropine were established by administering edrophonium (1 mg/kg) and atropine (10-20 micrograms/kg) to 24 infants and children. The smallest changes in heart rate and systolic blood pressure occurred when atropine (10 micrograms/kg) was given 30 s before edrophonium. The pharmacokinetics of edrophonium (1 mg/kg) were studied in four infants and four children and were compared with published values for adults: distribution and elimination half-lives and distribution volumes were similar for the three groups. Total clearance (ml.kg-1.min-1) was greatest for infants (17.8 +/- 1.2) compared with children (14.2 +/- 7.3) and adults (8.3 +/- 2.9). The authors conclude that the dose of edrophonium required toantagonize dTc-induced neuromuscular blockade is similar or possibly greater for infants and children than for adults.(ABSTRACT TRUNCATED AT 250 WORDS)